We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
9:00-9:15 – Opening
9:15-10.45– New treatments for old diseases Chair: Dra. Mar O’Callaghan, Hospital Sant Joan de Déu, Barcelona
Dra. Mireia del Toro, Hospital Vall d’Hebron, Barcelona "Lipofuscinosis: importance of early diagnosis and treatment"Dr. Jesús Villarrubia, Hospital Ramón y Cajal, Madrid "Niemann-Pick type B: new therapeutic opportunities"Dr. Antonio González Meneses, Hospital Virgen del Rocío, Sevilla "Update in diagnosis and treatment of the mucopolysaccharidosis" 10.45-11:15 – Coffee break 11:15-12.45 – New diagnostic approaches and research therapeutic strategies Chair: Dr. José Antonio Arranz, Hospital Vall d’Hebron, Barcelona
Dr. Cristóbal Colón, Hospital Universitario, Santiago de Compostela "Present situation of the newborn screening for lysosomal diseases"Dra. Ibane Abasolo, CIBBIM-Nanomedicina, Institut Recerca Vall d’Hebron, Barcelona "Therapeutic applications of extracellular vesicles as vehicles for lysosomal enzymes"
Dr. Víctor Álvarez, Hospital Universitario, Santiago de Compostela "Vehículos no virales: nueva aplicación para MPS IV"
Dra. Silvia Muro, University of Maryland (USA), ICREA - Institut de Bioingenieria de Catalunya, Barcelona "New means to enable blood-to-brain access of lysosomal enzyme therapies" 13:00 – 14:00 Buffet/Lunch 14:00-16:30 – Treatment and long-term evolution of Gaucher and Fabry diseases Chairs: Dr. Xavier Solanich, Hospital Bellvitge, and Dr. VicençTorregrosa, Hospital Clínic
Dr. Derralynn Hughes, Royal Free Hospital, UCL, London (UK) "Bone disease and malignancy in Gaucherdisease"Dr. Gregory Pastores, University College Dublin , Ireland "Guidelines and therapeutic goals in Gaucherdisease"Dr. Roser Torra, FundacióPuigvert, Barcelona "Early detection and long-term evolution of Fabrynephropathy" Dr. Guillem Pintos, Hospital UniversitariValld’Hebron, Barcelona 2Clinical phenotype and genotype in the management of young Fabrypatients"Dr. Derralynn Hughes, Royal Free Hospital, UCL ,London (UK) 2How to diagnose and treat female Fabrypatients"
Inscripcions clicant en aquest enllaç
Més Informació: Direcció de Comunicació, Màrqueting i RSC - Vall d’Hebron Barcelona Hospital Campus
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to email@example.com, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.